Skip to main content

Table 3 Postoperative outcomes

From: Impact of frailty on inpatient outcomes in thyroid cancer surgery: 10-year results from the U.S. national inpatient sample

  All patients
(n = 38,202)
Non-frailty
(n = 37,900)
Frailty
(n = 302)
p-value
In-hospital death     < 0.0001
 Alive 38,138
(99.83%)
37,847
(99.86%)
291
(96.36%)
 
 Dead 64
(0.17%)
53
(0.14%)
11
(3.64%)
 
Prolonged LOS     < 0.0001
 N (<75th percentile) (< 2 days) 22,932
(60.03%)
22,892
(60.40%)
40
(13.25%)
 
 Y (> = 75th percentile) (> = 2 days) 15,270
(39.97%)
15,008
(39.60%)
262
(86.75%)
 
Surgical complications 5388
(14.10%)
5253
(13.86%)
135
(44.70%)
< 0.0001
 Tracheostomy 38
(0.10%)
33
(0.09%)
5
(1.66%)
< 0.0001
 Hoarseness 270
(0.71%)
260
(0.69%)
10
(3.31%)
< 0.0001
 Hemorrhage, hematoma, or seroma 784
(2.05%)
734
(1.94%)
50
(16.56%)
< 0.0001
 Hypocalcemia 3587
(9.39%)
3540
(9.34%)
47
(15.56%)
0.0007
 Vocal cord paresis or paralysis 921
(2.41%)
866
(2.28%)
55
(18.21%)
< 0.0001
 Wound/ Technical complications 453
(1.19%)
427
(1.13%)
26
(8.61%)
< 0.0001
Medical complications 2690
(7.04%)
2523
(6.66%)
167
(55.30%)
< 0.0001
 Cardiovascular 1672
(4.38%)
1600
(4.22%)
72
(23.84%)
< 0.0001
 Pulmonary 521
(1.36%)
450
(1.19%)
71
(23.51%)
< 0.0001
 Acute kidney injury 190
(0.50%)
155
(0.41%)
35
(11.59%)
< 0.0001
 Pneumonia 604
(1.58%)
515
(1.36%)
89
(29.47%)
< 0.0001
 Infection/Sepsis 397
(1.04%)
336
(0.89%)
61
(20.20%)
< 0.0001